Showing results (201-210 of 479) with videos related to

Sort By:
Pageof 48
Drug and Alcohol Dependence|May 21, 2018
Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomesBrian Eastwood, John Strang, John Marsden
Journal of Interprofessional Care|December 12, 2018
Challenges in delivering personalised support to people with multiple and complex needs: qualitative studyJoanne Neale, Tom Parkman, John Strang
Addiction (Abingdon, England)|May 15, 2026
Characteristics of deaths due to drug-related causes among individuals recently released from prison in the United Kingdom, 1997-2025Emmert Roberts, John Strang, Caroline Copeland
The International Journal on Drug Policy|June 6, 2024
'Matters-of-concern' associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative studyStephen Parkin, Joanne Neale, John Strang
Drug and Alcohol Dependence|June 1, 2024
Booster effects and mechanisms of web-based personalised normative feedback alcohol intervention for college students: A pragmatic randomised controlled trialAndre Bedendo, Jacques Gaume, Jim McCambridge, et al.
BMC Research Notes|June 23, 2010
How big is the elephant in the room? Estimated and actual IT costs in an online behaviour change trialJim McCambridge, Orla O'Donnell, Christine Godfrey, et al.
Research in Social & Administrative Pharmacy : RSAP|February 7, 2021
Process study within a pilot cluster randomised trial in community pharmacy: An exploration of pharmacist readiness for researchDuncan Stewart, Mary Madden, Anne Van Dongen, et al.
Drug and Alcohol Review|March 1, 2021
Introducing alcohol as a drug in medicine reviews with pharmacists: Findings from a co-design workshop with patientsMary Madden, Stephanie Morris, Margaret Ogden, et al.
Addictive Behaviors|December 23, 2008
Test-retest reliability of an online measure of past week alcohol consumption (the TOT-AL), and comparison with face-to-face interviewZarnie Khadjesari, Elizabeth Murray, Eleftheria Kalaitzaki, et al.
Addiction (Abingdon, England)|June 6, 2016
Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchersNiamh Fitzgerald, Kathryn Angus, Andrew Elders, et al.
Pageof 48